Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
486
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates

Ehab L. Atallaha Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Islam Sadekb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
,
Rodrigo Maegawab Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
,
Xiting Caob Novartis Pharmaceuticals Corporation, East Hanover, NJ, USACorrespondence[email protected]
View further author information
,
Dominick Latremouille-Viauc Analysis Group, Inc, Montreal, CanadaView further author information
,
Irina Pivnevac Analysis Group, Inc, Montreal, CanadaView further author information
,
Carmine Rossic Analysis Group, Inc, Montreal, CanadaView further author information
,
Annie Guerinc Analysis Group, Inc, Montreal, CanadaView further author information
&
Vamsi Kotad Georgia Cancer Center at Augusta University, Augusta, GA, USAView further author information
 show all
Pages 1730-1739 | Received 16 Sep 2020, Accepted 29 Jan 2021, Published online: 01 Mar 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hong Chen, Yuming Zhang, Yirong Jiang, LiE Lin, Shuqin Cheng, Xiaojun Xu, Xiong Zhang, Haiqing Lin, Zhenqian Huang, Qiang Wang, Xuan Zhou, Hong Qu, Xiaoli Liu, Weiming Li & Na Xu. (2023) Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey. Leukemia & Lymphoma 64:8, pages 1458-1464.
Read now

Articles from other publishers (1)

Sherrie Mikhaeel & Ehab Atallah. (2023) SOHO State of the Art Updates and Next Questions | Update on Treatment-Free Remission in Chronic Myeloid Leukemia (CML). Clinical Lymphoma Myeloma and Leukemia 23:5, pages 333-339.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.